“…Omadacycline tosylate from MedChemExpress has been used in at least 19 published studies ( 3 ), 6 of which are in ASM journals, 3 specifically in Antimicrobial Agents and Chemotherap y. Upon review of these 19 publications, omadacycline tosylate claims include, but are not limited to, in vitro potency, impact of resistance mechanisms on in vitro activity, and the propensity to select for mutations associated with resistance ( 3 – 10 ). As such, this analysis was performed to understand how the MedChemExpress powder performs when put through the validated, approved analytical methods used for the Paratek drug substance.…”